Covalon TechnologiesCVALF -1.79%83 PS Ratio is 1.77 as of Jul. 09, 2026, which is 30% below its 10-year median of 2.54. GuruFocus rates CVALF with a GF Score™ of 83/100 and a GF Value™ of $1.53 (Fairly Valued). The stock has 2 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Covalon Technologies ranks better than 63.43% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Covalon Technologies's share price is $1.51.
Covalon Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.86. Hence, Covalon Technologies's PS Ratio for today is 1.77.
The historical rank and industry rank for Covalon Technologies's PS Ratio or its related term are showing as below:
CVALF'
s PS Ratio Range Over the Past 10 Years
Min: 0.83 Med: 2.54 Max: 11.73
Current: 1.81
During the past 13 years, Covalon Technologies's highest PS Ratio was 11.73. The lowest was 0.83. And the median was 2.54.
CVALF's PS Ratio is ranked better than 63.43% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.93
vs CVALF: 1.81
Covalon Technologies Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Covalon Technologies was -8.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 18.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 18.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.40% per year.
During the past 13 years, Covalon Technologies's highest 3-Year average Revenue per Share Growth Rate was 46.30% per year. The lowest was -27.40% per year. And the median was 13.70% per year.
Back to Basics: PS Ratio
Covalon Technologies (OTCPK:CVALF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Covalon Technologies PS Ratio Related Terms
Covalon Technologies PS Ratio Historical Data
* Premium members only.
The historical data trend for Covalon Technologies's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Covalon Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Covalon Technologies PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Covalon Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Covalon Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Covalon Technologies's Share Price of today is $1.51. Covalon Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Covalon Technologies (CVALF) has a PS Ratio of 1.77 as of Jul. 09, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Covalon Technologies and its competitors. This is 30% below median its historical median of 2.54. Over the past decade, Covalon Technologies' PS Ratio has ranged from 0.83 to 11.73. According to the industry distribution chart, Covalon Technologies ranks #294 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 36.6%.
Is Covalon Technologies' PS Ratio too high?
Covalon Technologies' current PS Ratio of 1.77 is 30% below median its 10-year median of 2.54. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 11.73. The Medical Devices & Instruments industry median PS Ratio is 2.93. Covalon Technologies' value of 1.77 is 39.6% below this industry median. Based on the distribution chart, Covalon Technologies ranks #294 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Covalon Technologies has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Covalon Technologies ranks #294 out of 804 companies for PS Ratio. This puts Covalon Technologies in the upper half of its industry. The industry median PS Ratio is 2.93. Covalon Technologies' value of 1.77 is 39.6% below this benchmark. Historically, Covalon Technologies' own PS Ratio has ranged from 0.83 to 11.73 over the past decade. While the company's 10-year median is 2.54 vs. the industry median of 2.93, Covalon Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.93, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Covalon Technologies's current PS Ratio of 1.77 is 39.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Covalon Technologies and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Covalon Technologies's current PS Ratio is 1.77, which is 30% below median its own 10-year median of 2.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Fairly Valued. The stock's GF Value™ is $1.53, compared to a current price of $1.51 — trading 1.3% below its estimated fair value. The current PS Ratio is 1.77, which is 30% below median its 10-year median of 2.54 and 39.6% below the Medical Devices & Instruments industry median of 2.93. Covalon Technologies' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current PS Ratio is 1.77 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Covalon Technologies (CVALF) Overvalued in 2026?
Based on GuruFocus' analysis, Covalon Technologies stock appears to be undervalued.
The current stock price of $1.51 is trading 1.3% below its estimated GF Value™ of $1.53.
GuruFocus considers Covalon Technologies to be Fairly Valued.
Key valuation signals for CVALF:
PS Ratio: 1.77 (30% below median its 10-year median of 2.54)
GF Value™: $1.53 vs. price of $1.51 (1.3% below fair value)
Industry Position: 39.6% below the Medical Devices & Instruments median (#294 of 804)
No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
83GF Score
Get the complete analysis for CVALF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVALF has been successfully added to your 
